10x Genomics
TXG
$14.00
Share price
-4.37%
Change (1 day)
-31.07%
Change (1 year)
Categories
10x Genomics (TXG) Fails to deliver data
Key failure to deliver metrics for 10x Genomics :
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.36 M
- Last year FTD volume: $0.36 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for 10x Genomics (TXG) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for 10x Genomics (TXG) - since 2019
Volume in USD (price x number of shares), data since 201910x Genomics (TXG) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $1.96 M | -79.68% |
| 2024 | $9.67 M | -85.12% |
| 2023 | $65 M | 155.25% |
| 2022 | $25.46 M | -77.4% |
| 2021 | $0.11 B | -66.61% |
| 2020 | $0.33 B | 3105.42% |
| 2019 | $10.52 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novocure
NVCR | $0.4 M | $2.92 M | Jersey |
 Novavax NVAX | $24.74 M | $93.35 M | 🇺🇸 USA |
 Organovo ONVO | $1.48 M | $1.48 M | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | N/A | $0.31 M | 🇬🇧 UK |